Document is current
Any future updates will be listed below
-
Authors
van de Kerkhof, Peter C. M.
- License Information
-
More Information
Article History
Accepted: 19 October 2021
First Online: 21 January 2022
Declarations
:
: This article has been published as part of a journal supplement wholly funded by Boehringer Ingelheim.
: The author did not receive payment related to the development of the manuscript.
: PvdK received fees for consultancy service or lecturerships from Almirall, AbbVie, Eli Lilly, Novartis, Janssen Pharmaceutics, LEO Pharma, Bristol Myers Squibb, UCB, Boehringer Ingelheim, and Dermavant.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Written by Peter van de Kerkhof.
